Denver CO – 
(NewMediaWire) – December 07, 2021 – CBD Global Sciences, Inc. (OTC: CBDNF) (CSE: CBDN) (Frankfurt:GS3), (“CBD Global” or the “Company”), is pleased to share that it is adding new brands to its growing distribution channel.
Legacy Distribution Group, “Legacy Distribution” (Denver, CO) is one of the country’s first CBD-focused Direct Store Delivery (DSD) distributors. Dedicated to providing “Best in Class” products to its retailers, we are focused on introducing both CBD and non-CBD product lines. Legacy Distribution Group is excited to announce the addition of Lil’ Baby’s Oowee Lemonade by RAP SNACKS® to its family of brands, a non-CBD product line. Legacy has executed an exclusive distribution agreement with RAP SNACKS® for its Colorado and Wyoming territories. Rap Snacks Lil’ Baby’s Oowee Lemonade comes in five flavors, Fruit Punch, Strawberry Watermelon, Mango Pineapple, Blueberry, and Sweet Tea. The lemonades are available nationally in stores that sell the Rap Snacks brand product line.
Brad Wyatt, CEO of CBD Global Sciences, shared, “James Lindsay and his team at Rap Snacks never cease to amaze me with their product offerings. We’re confident that Lil’ Baby’s Oowee Lemonade rolling out in Colorado and Wyoming will prove to be a huge success for both our companies; they’ve really done an incredible job with this drink line! I am confident that the demand for this product will grow quickly.”
ABOUT RAP SNACKS®
RAP SNACKS® was founded in 1994 by James Lindsay, the founder and current CEO of Rap Snacks. He and his team has created a synergy between well-known and ‘up and coming’ hip-hop artists by developing for each artist their own special flavor and branding. The snack bags have an artistic rendition of the hip-hop artist on the front of the bag with each having its own special flavor. On the back of each bag is a QR code which allows the consumer to get a special message from the artist.
James Lindsay has had two passions from day one, there was never any doubt that Lindsay’s career would incorporate both food and music. “As a kid, I considered myself a snack food connoisseur,” Lindsay says. Like some sort of snack-mad scientist, he would often take various types of chips and mix them together in one bag in search of the next great flavor, to keep one step ahead of what was currently on the market. “I just think that hip-hop is so open, it has no limitations. And it connects with different brands and products right now because it’s dominant. It’s the most dominant category in music right now. Everybody’s rapping now. No matter what color you are, what’s your background, everybody’s rapping. It’s a way to express yourself in a very truthful and honest manner.”
Previous artists featured among Rap Snacks lineup include Ol’ Dirty Bastard, Master P, Meek Mill, Yung Joc, Bell Biv Devoe, Baby, Big Tymers, Pretty Willie, Ms. Toi, Mack 10, and Pastor Troy.
ABOUT CBD GLOBAL SCIENCES INC.
CBD Global Sciences, Inc., is a hemp-based CBD producer and branding investment vehicle which currently owns two brands, branded under the name Aethics™ (www.aethics.com) and CANNAOIL (www.cannaoilshop.com), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, Hydration products and Confectionary products. CBD Global Sciences hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.
CBD Global Sciences, through its wholly owned subsidiaries, Global Sciences Holdings, Resinosa LLC (www.resinosa.com) and Legacy Distribution Group, (www.legacydistributiongroup.com), is delivering quality CBD products both in a retail and e-commerce formats nationwide. The Direct Store Delivery (DSD) provides distribution services for multiple vendors of CBD infused products and non-CBD products throughout the Colorado and Wyoming territories that are currently servicing over 750 C-store and large box retailers with expansion plans to exceed 5,000 stores in the next 12-24 months. In addition to Legacy Distribution it has added a manufacturing division, Resinosa LLC (www.Resinosa.com), with its capabilities to provide cGMP manufacturing to the CBD industry with both private label and white label CBD and non-CBD product lines.
For further information, please contact Investor Relations at 720-881-2510, info@cbdglobalsciences.com
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to future developments and the business and operations of the Corporation after the CSE listing. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. Readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.